News from aspenbio pharma, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 20, 2012, 16:10 ET

AspenBio Pharma Announces Closing of Public Offering of 1,946,000 Shares of Common Stock

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced the closing of an underwritten public offering of...

Nov 14, 2012, 20:55 ET

AspenBio Pharma Announces Pricing of Public Offering of 1,476,000 Shares of Common Stock

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, announced today the pricing of its previously announced underwritten...

Nov 14, 2012, 16:40 ET

AspenBio Pharma Announces Proposed Public Offering

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced its intention, subject to market and other...

Nov 13, 2012, 16:35 ET

AspenBio to Present at 2012 Lazard Capital Markets Healthcare Conference

AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will present at the 9th Annual Lazard Capital...

Nov 13, 2012, 16:05 ET

AspenBio Pharma Begins Training Hospital Sites for Pivotal Clinical Trial

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today provided a clinical and business update for the third quarter...

Nov 06, 2012, 07:30 ET

AspenBio Engages European-based Sales and Marketing Veteran Miquel Vernet to Consult on European Commercialization

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced it has engaged Miquel Vernet to consult with the Company...

Oct 15, 2012, 07:30 ET

AspenBio Proposes Corporate Name Change to Venaxis, Inc.

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will ask its shareholders to approve changing...

Sep 27, 2012, 07:28 ET

AspenBio Plans to Initiate Pivotal Study in Fourth Quarter

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today provided its shareholders and the broader investment community...

Sep 25, 2012, 07:30 ET

AspenBio to Provide Investors with Clinical and Business Update

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will host a conference call and live audio...

Sep 20, 2012, 07:30 ET

AspenBio to Present at 2012 Aegis Healthcare Conference

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will present at the 2012 Aegis Healthcare...

Sep 18, 2012, 16:20 ET

AspenBio Announces Dismissal of Class Action and Chipman Lawsuits by U. S. District Court

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that the United States District Court for Colorado has...

Sep 04, 2012, 08:00 ET

AspenBio to Present at Rodman & Renshaw Annual Global Investment Conference

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will present at the Rodman & Renshaw Annual...

Aug 15, 2012, 16:05 ET

AspenBio Pharma Focuses Resources on Development of AppyScore™ Clinical Diagnostic Test

AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today provides its investors and the broader investment and medical...

Aug 08, 2012, 08:20 ET

AspenBio Pharma to Provide Shareholders with Business Update

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, announced that it will begin hosting regular conference calls to...

Aug 07, 2012, 08:20 ET

AspenBio Pharma Submits Pre-IDE Information Package to FDA for AppyScore™ Appendicitis Test System

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, announced that it has submitted a pre-IDE (Investigational Device...

Aug 01, 2012, 08:20 ET

AspenBio Pharma Enhances Product Development & Manufacturing Capabilities in Preparation for Clinical Trial and Commercialization of AppyScore™

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, announced that Lyndal Hesterberg, Ph.D., has agreed to lead the...

Jul 30, 2012, 08:20 ET

AspenBio Pharma Executes Worldwide License Agreement for its Animal Health Assets

 AspenBio Pharma, Inc. (Nasdaq: APPY) today announced that it has executed an exclusive worldwide license agreement with a major international...

Jul 26, 2012, 17:20 ET

AspenBio Pharma Engages Tiberend Strategic Advisors as Investor and Public Relations Agency of Record

 AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercialization for its lead...

Feb 14, 2008, 00:00 ET

AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference

CASTLE ROCK, Colo., Feb. 14 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc. (Nasdaq: APPY) an emerging bio-pharmaceutical company dedicated to...

Dec 27, 2007, 00:00 ET

AspenBio Outlines Steps for FDA 510(k) Clearance of AppyScore(TM), the First Blood-Based Screen/Triage Test for Human Appendicitis

CASTLE ROCK, Colo., Dec. 27 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an emerging bio-pharmaceutical company dedicated to...